Matches in SemOpenAlex for { <https://semopenalex.org/work/W2132160242> ?p ?o ?g. }
- W2132160242 endingPage "49" @default.
- W2132160242 startingPage "41" @default.
- W2132160242 abstract "Phenobarbital (PB) is a non-genotoxic liver tumor promoter used extensively in initiation–promotion protocols. To determine the mode of PB action, double transgenic mice overexpressing both the c-myc and transforming growth factor (TGF)-α genes were treated with PB in the food for 10 weeks, from 3 weeks of age. After 3–4 weeks on PB a peak in liver mass was noted, which subsequently leveled off at a value ~30% above untreated animals. The mitotic index in mice given PB peaked at 1 week of treatment and was significantly elevated compared with untreated animals. No significant difference between treated and untreated animals was seen thereafter, although a trend of PB-associated mitotic suppression was noticeable. The apoptotic index also showed a trend of suppression compared with untreated animals, significant after prolonged PB administration. Dysplastic hepatocytes were more prominent in PB-treated mice than untreated animals, particularly pericentrally. Removal of PB from the diet at 4 weeks of treatment led to a dramatic increase in apoptosis. This accompanied a drop in the liver mass to the level of untreated controls by 10 days. Throughout the study, PB-treated animals showed markedly lower levels of TGF-β1 ligand, coincident with an elevated level of the anti-apoptotic protein Bcl-2. On withdrawal of PB, the levels of all these proteins rapidly changed to mirror those seen in untreated mice. In all treatment groups, no change in the levels of epidermal growth factor receptor, TGF-β receptors I and II or Bcl-xS/L were seen. We conclude from our data that PB stimulates liver growth in double transgenic c-myc/TGF-α mice by induction of liver hypertrophy and inhibition of apoptosis, brought about by both a decrease in signaling through the TGF-β pathway and an increase in Bcl-2. The data support the hypothesis that PB promotes neoplastic development through a reduction in the incidence of cell death." @default.
- W2132160242 created "2016-06-24" @default.
- W2132160242 creator A5087862269 @default.
- W2132160242 creator A5088131174 @default.
- W2132160242 date "1999-01-01" @default.
- W2132160242 modified "2023-09-25" @default.
- W2132160242 title "Phenobarbital promotes liver growth in c-myc/TGF-α transgenic mice by inducing hypertrophy and inhibiting apoptosis" @default.
- W2132160242 cites W1621124914 @default.
- W2132160242 cites W1644953918 @default.
- W2132160242 cites W1964253362 @default.
- W2132160242 cites W1970834072 @default.
- W2132160242 cites W1973060929 @default.
- W2132160242 cites W1979420835 @default.
- W2132160242 cites W1979995768 @default.
- W2132160242 cites W1982882974 @default.
- W2132160242 cites W1985496253 @default.
- W2132160242 cites W1985874805 @default.
- W2132160242 cites W1987808828 @default.
- W2132160242 cites W1992068755 @default.
- W2132160242 cites W1993112793 @default.
- W2132160242 cites W1993620754 @default.
- W2132160242 cites W1996522179 @default.
- W2132160242 cites W2019900532 @default.
- W2132160242 cites W2020136896 @default.
- W2132160242 cites W2029107720 @default.
- W2132160242 cites W2031223075 @default.
- W2132160242 cites W2032064739 @default.
- W2132160242 cites W2033873142 @default.
- W2132160242 cites W2045295079 @default.
- W2132160242 cites W2046788650 @default.
- W2132160242 cites W2058591356 @default.
- W2132160242 cites W2060184613 @default.
- W2132160242 cites W2062946012 @default.
- W2132160242 cites W2065857667 @default.
- W2132160242 cites W2086649402 @default.
- W2132160242 cites W2093329745 @default.
- W2132160242 cites W2099941826 @default.
- W2132160242 cites W2104980108 @default.
- W2132160242 cites W2130866079 @default.
- W2132160242 cites W2132969614 @default.
- W2132160242 cites W2134872883 @default.
- W2132160242 cites W2158951763 @default.
- W2132160242 cites W2164467062 @default.
- W2132160242 cites W2167804500 @default.
- W2132160242 cites W2336306332 @default.
- W2132160242 cites W3021565715 @default.
- W2132160242 cites W4253817526 @default.
- W2132160242 doi "https://doi.org/10.1093/carcin/20.1.41" @default.
- W2132160242 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9934848" @default.
- W2132160242 hasPublicationYear "1999" @default.
- W2132160242 type Work @default.
- W2132160242 sameAs 2132160242 @default.
- W2132160242 citedByCount "26" @default.
- W2132160242 countsByYear W21321602422014 @default.
- W2132160242 countsByYear W21321602422016 @default.
- W2132160242 crossrefType "journal-article" @default.
- W2132160242 hasAuthorship W2132160242A5087862269 @default.
- W2132160242 hasAuthorship W2132160242A5088131174 @default.
- W2132160242 hasBestOaLocation W21321602421 @default.
- W2132160242 hasConcept C102230213 @default.
- W2132160242 hasConcept C104317684 @default.
- W2132160242 hasConcept C118131993 @default.
- W2132160242 hasConcept C126322002 @default.
- W2132160242 hasConcept C134018914 @default.
- W2132160242 hasConcept C141035611 @default.
- W2132160242 hasConcept C167414201 @default.
- W2132160242 hasConcept C170493617 @default.
- W2132160242 hasConcept C190283241 @default.
- W2132160242 hasConcept C2778793413 @default.
- W2132160242 hasConcept C29730261 @default.
- W2132160242 hasConcept C55493867 @default.
- W2132160242 hasConcept C66640590 @default.
- W2132160242 hasConcept C71924100 @default.
- W2132160242 hasConcept C86803240 @default.
- W2132160242 hasConcept C93304396 @default.
- W2132160242 hasConcept C95444343 @default.
- W2132160242 hasConceptScore W2132160242C102230213 @default.
- W2132160242 hasConceptScore W2132160242C104317684 @default.
- W2132160242 hasConceptScore W2132160242C118131993 @default.
- W2132160242 hasConceptScore W2132160242C126322002 @default.
- W2132160242 hasConceptScore W2132160242C134018914 @default.
- W2132160242 hasConceptScore W2132160242C141035611 @default.
- W2132160242 hasConceptScore W2132160242C167414201 @default.
- W2132160242 hasConceptScore W2132160242C170493617 @default.
- W2132160242 hasConceptScore W2132160242C190283241 @default.
- W2132160242 hasConceptScore W2132160242C2778793413 @default.
- W2132160242 hasConceptScore W2132160242C29730261 @default.
- W2132160242 hasConceptScore W2132160242C55493867 @default.
- W2132160242 hasConceptScore W2132160242C66640590 @default.
- W2132160242 hasConceptScore W2132160242C71924100 @default.
- W2132160242 hasConceptScore W2132160242C86803240 @default.
- W2132160242 hasConceptScore W2132160242C93304396 @default.
- W2132160242 hasConceptScore W2132160242C95444343 @default.
- W2132160242 hasIssue "1" @default.
- W2132160242 hasLocation W21321602421 @default.
- W2132160242 hasLocation W21321602422 @default.
- W2132160242 hasOpenAccess W2132160242 @default.
- W2132160242 hasPrimaryLocation W21321602421 @default.